Your browser doesn't support javascript.
loading
Midterm follow-up (3 years) confirms and extends short-term results of intravesical gemcitabine as bladder-preserving treatment for non-muscle-invasive bladder cancer after BCG failure.
Hurle, Rodolfo; Contieri, Roberto; Casale, Paolo; Morenghi, Emanuela; Saita, Alberto; Buffi, Nicolòmaria; Lughezzani, Giovanni; Colombo, Piergiuseppe; Frego, Nicola; Fasulo, Vittorio; Paciotti, Marco; Guazzoni, Giorgio; Lazzeri, Massimo.
Afiliación
  • Hurle R; Department of Urology, Humanitas Clinical and Research Center - IRCCS, Milan, Italy.
  • Contieri R; Department of Urology, Humanitas Clinical and Research Center - IRCCS, Milan, Italy.
  • Casale P; Department of Urology, Humanitas Clinical and Research Center - IRCCS, Milan, Italy.
  • Morenghi E; Department of Medical Statistic, Humanitas Clinical and Research Center - IRCCS, Milan, Italy.
  • Saita A; Department of Urology, Humanitas Clinical and Research Center - IRCCS, Milan, Italy.
  • Buffi N; Department of Urology, Humanitas Clinical and Research Center - IRCCS, Milan, Italy; Department of Medical Statistic, Humanitas Clinical and Research Center - IRCCS, Milan, Italy; Department of Urology, Department of Biomedical Sciences, Pieve Emanuele - Milano, Italy.
  • Lughezzani G; Department of Urology, Humanitas Clinical and Research Center - IRCCS, Milan, Italy; Department of Urology, Department of Biomedical Sciences, Pieve Emanuele - Milano, Italy.
  • Colombo P; Department of Pathology, Humanitas Clinical and Research Center - IRCCS, (Milan), Italy.
  • Frego N; Department of Urology, Humanitas Clinical and Research Center - IRCCS, Milan, Italy.
  • Fasulo V; Department of Urology, Humanitas Clinical and Research Center - IRCCS, Milan, Italy.
  • Paciotti M; Department of Urology, Humanitas Clinical and Research Center - IRCCS, Milan, Italy.
  • Guazzoni G; Department of Urology, Humanitas Clinical and Research Center - IRCCS, Milan, Italy; Department of Urology, Department of Biomedical Sciences, Pieve Emanuele - Milano, Italy.
  • Lazzeri M; Department of Urology, Humanitas Clinical and Research Center - IRCCS, Milan, Italy. Electronic address: massimo.lazzeri@humanitas.it.
Urol Oncol ; 39(3): 195.e7-195.e13, 2021 03.
Article en En | MEDLINE | ID: mdl-33268275
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Desoxicitidina / Antimetabolitos Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Desoxicitidina / Antimetabolitos Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2021 Tipo del documento: Article